China's self-developed lung cancer drug available nationwide - Xinhua
Source: Xinhua| Editor: huaxia Video PlayerClose HANGZHOU, Dec. 17 (Xinhua) -- Ensartinib hydrochloride, a targeted drug for lung cancer developed by a Chinese firm, has been available in hospitals and pharmacies nationwide since Wednesday, according to its developer Beta Pharma. The Guangzhou-based Sun Yat-sen University Cancer Center prescribed the medication on Wednesday, first in China. Lung cancer is China's leading cause of mortality and morbidity in malignant tumor diseases, among which about 80 to 85 percent are non-small cell lung cancers (NSCLCs). Anaplastic Lymphoma Kinase (ALK), o...
Source: xinhuanet.com